Abbott India Limited announced at the Board of Directors at its Meeting held on May 19, 2023 that the company approved appointment of Mr. Sridhar Kadangode as Chief Financial Officer and Key Managerial Personnel of the Company effective July 1, 2023. Mr. Sridhar Kadangode has overall 25 years' of diversified experience in finance function and is
currently the Director - Finance of the Company, managing Finance Demand Planning and Business Compliance function. During his tenure, he has led a strong financial performance
through the pandemic, both in topline and bottom line with the focus on future growth. He has also redesigned the 5-year strategic financial plan for the Company. Prior to this role in the Company, Sridhar has worked with Nutrition business of Abbott Healthcare Private Limited. He was part of the core management team which evolved the path to profitability
for the business for South Asia and overdelivered bottom line for consecutive three years. He has led some of the key business projects linked to demonetization, distributor optimization and cost leadership initiatives. Sridhar started his professional journey with Britannia Industries and then moved to Danone where he handled multiple assignments overseas (Singapore, US, Malaysia, South Africa) before moving back to India in 2011. He was responsible for Finance, Supply Chain and Procurement functions in his last assignment in Danone prior to joining Abbott Healthcare in 2014. His key accomplishments with Danone include reorganization of business model, implementation of Supply Chain efficiency projects and transformation of Finance function into a key business partner in driving the business. Sridhar is a Member of the Institute of Chartered Accountants of India and Institute of Cost and Management Accountants of India.